AI assistant
Sending…
CONMED Corp — Director's Dealing 2013
May 31, 2013
31971_dirs_2013-05-31_38c7817c-bd4d-42b3-ba52-249ab095c829.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-05-29
Reporting Person: POMILIO LUKE A (Vice President & Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-29 | Common Stock | M | 10000 | $19.93 | Acquired | 25720 | Direct |
| 2013-05-29 | Common Stock | F | 7444 | $33.27 | Disposed | 18276 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-29 | Sars (Stock Appreciation Rights) | $19.93 | M | 10000 | Disposed | 2016-05-16 | Common Stock (10000) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7